ea0081ep715 | Pituitary and Neuroendocrinology | ECE2022
Amereller Felix
, Jochen Schopohl
, Sylvere Stormann
, Martin Bidlingmaier
, Peter Rieckmann
, Philipp Gulde
Background: Although the prognosis inGuillain-Barré syndrome (GBS) is generally good, the protracted and sometimes incomplete recovery is a heavy burden for patients. Animal studies suggest that treatment with growth hormone (GH) could stimulate myelin repair and thus accelerate functional recovery in acute polyneuropathy. We report on the first use of GH in GBS.Objective: To monitor safety and tolerability as well as to evaluate the effect of off-l...